Acc Cardiacast
ACC CardiaCast: Emerging Data in SGLT2 Inhibitors
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:11:43
- Mas informaciones
Informações:
Sinopsis
This podcast discusses new data pertaining to the class of SGLT2 inhibitors in the treatment of diabetes and its cardioprotective properties. As the incidence of type 2 diabetes mellitus rises in the United States, understanding the results of the EMPA-REG OUTCOME (Empagliflozin Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients) trial will help prepare you to better treat your patients.
